Welcome to CDC Stacks | Agency for Toxic Substances and Disease Registry justification of appropriation estimates for Appropriations Committees fiscal year 2012 - 26577 | Stephen B. Thacker CDC Library collection
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Agency for Toxic Substances and Disease Registry justification of appropriation estimates for Appropriations Committees fiscal year 2012
  • Published Date:
    2/14/11
  • Language:
    English
Filetype[PDF - 602.68 KB]


Details:
  • Corporate Authors:
    United States. Agency for Toxic Substances and Disease Registry.
  • Description:
    We are pleased to present the FY 2012 Congressional Justification for the Agency for Toxic Substances and Disease Registry (ATSDR). ATSDR serves the public through responsive public health actions to promote healthy and safe environments and to prevent harmful exposures. ATSDR continues to prevent, determine, and mitigate health effects at sites with toxic exposures, and its successes in doing so across the nation illustrate how funding for ATSDR directly benefits Americans. Just a few of ATSDR’s successes in FY 2010 are highlighted below:

    Completed a multiyear, multisite study in North Carolina of health effects due to toluene diisocyanate (TDI), a substance known to be the largest contributor to occupationally-induced asthma. This study is important because while much is known about job-related exposures, there is very little information on how low levels of TDI exposure affect the health of the general public. To examine community level health effects, ATSDR utilized new methods for detecting the chemical in the communities’ ambient air, by testing people’s blood for exposures, and by assessing the prevalence of asthma and other respiratory diseases in participants near emitting facilities as compared to residents further from these TDI emitting facilities.

    Completed a research study of Ig Gene Sequencing for Monoclonal B-Cell Lymphocytosis (MBL) cases to help increase knowledge of fundamental events associated with the neoplastic process in B- cell lymphoproliferative diseases (BLPD) and permit early detection of the BLPD. The study helped determine whether MBL can be used as a biomarker associated with exposure to hazardous wastes and whether individuals with MBL who are more likely to progress to a BLPD can be identified.

    Collaborated with EPA on the development of human health benchmarks for chemical contaminants in the Gulf of Mexico from the Deepwater Horizon Oil Spill.

    ATSDR monitors its performance through long-term performance measures that evaluate our success in mitigating exposures at the most urgent and hazardous sites. These measures assess and document the impact of ATSDR’s efforts on the health of people exposed to toxic substances.

    This FY 2012 Congressional Justification provides more detail of ATSDR’s successes, highlights current efforts, and describes how the budget request will allow us to continue serving Americans productively through the upcoming fiscal year.

  • Document Type:
  • Supporting Files:
    No Additional Files
No Related Documents.
You May Also Like: